专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06972119B2 Apparatus for forming hydrogen 失效
标题翻译：用于形成氢的装置
公开(公告)号：US06972119B2
公开(公告)日：2005-12-06
申请号：US10168854
申请日：2000-12-27
申请人： Kiyoshi Taguchi , Takeshi Tomizawa , Kunihiro Ukai , Toshiyuki Shono , Koichiro Kitagawa , Tetsuya Ueda , Seiji Fujihara , Yutaka Yoshida
发明人： Kiyoshi Taguchi , Takeshi Tomizawa , Kunihiro Ukai , Toshiyuki Shono , Koichiro Kitagawa , Tetsuya Ueda , Seiji Fujihara , Yutaka Yoshida
IPC分类号： B01J8/04 , B01J19/24 , B01J23/40 , B01J23/63 , B01J23/72 , B01J35/00 , C01B3/16 , C01B3/48 , C01B3/58 , C10K3/04 , H01M8/06 , B01J3/00
CPC分类号： H01M8/0631 , B01J8/0453 , B01J8/0457 , B01J8/0488 , B01J8/0496 , B01J19/2485 , B01J23/40 , B01J23/63 , B01J23/72 , B01J35/0006 , B01J2208/00061 , B01J2208/00194 , B01J2208/00504 , B01J2208/00716 , B01J2219/0004 , B01J2219/00198 , B01J2219/002 , B01J2219/00202 , B01J2219/00213 , B01J2219/00231 , C01B3/16 , C01B3/48 , C01B3/583 , C01B3/586 , C01B2203/0233 , C01B2203/0283 , C01B2203/0288 , C01B2203/044 , C01B2203/0445 , C01B2203/047 , C01B2203/066 , C01B2203/0811 , C01B2203/0816 , C01B2203/085 , C01B2203/0866 , C01B2203/0877 , C01B2203/0883 , C01B2203/0894 , C01B2203/1023 , C01B2203/1041 , C01B2203/1064 , C01B2203/107 , C01B2203/1076 , C01B2203/1082 , C01B2203/1223 , C01B2203/1241 , C01B2203/1247 , C01B2203/1604 , C01B2203/1609 , C01B2203/1619 , C01B2203/1661 , C01B2203/169 , C01B2203/1695 , C01B2203/82 , C10K3/04 , Y02P20/52
摘要： A hydrogen producing apparatus comprising: a reforming section having a reforming catalyst which causes a reaction between a carbon-containing organic compound as a feedstock and water; a feedstock supply section for supplying the feedstock to the reforming section; a water supply section for supplying water to the reforming section; a heating section for heating the reforming catalyst; a shifting section having a shift catalyst which causes a shift reaction between carbon monoxide and water contained in a reformed gas supplied from the reforming section; and a purifying section having a purifying catalyst which causes oxidation or methanation of carbon monoxide contained in a gas supplied from the shifting section, wherein the shift catalyst comprises a platinum group metal and a metal oxide.
摘要翻译：一种制氢装置，其特征在于，包括：重整部，其具有使作为原料的含碳有机化合物与水发生反应的重整催化剂; 原料供给部，用于将原料供给至重整部; 供水部，其向所述重整部供给水; 用于加热所述重整催化剂的加热部分; 具有变换催化剂的换档部分，其引起从重整部分供应的重整气体中包含的一氧化碳和水之间的转化反应; 以及净化部，其具有使从所述变速部供给的气体中含有的一氧化碳发生氧化或甲烷化的净化催化剂，所述变换催化剂含有铂族金属和金属氧化物。

2. 发明授权

US06797420B2 Power generation device and operation method therefor 有权
标题翻译：发电装置及其运行方法
公开(公告)号：US06797420B2
公开(公告)日：2004-09-28
申请号：US09914376
申请日：2001-12-03
申请人： Kunihiro Ukai , Takeshi Tomizawa , Kiyoshi Taguchi , Toshiyuki Shono , Koichiro Kitagawa , Tomonori Asou , Masataka Ozeki , Shinji Miyauchi , Akira Maenishi , Yutaka Yoshida
发明人： Kunihiro Ukai , Takeshi Tomizawa , Kiyoshi Taguchi , Toshiyuki Shono , Koichiro Kitagawa , Tomonori Asou , Masataka Ozeki , Shinji Miyauchi , Akira Maenishi , Yutaka Yoshida
IPC分类号： H01M804
CPC分类号： H01M8/04425 , B01J8/0457 , B01J2208/00061 , B01J2208/00309 , B01J2208/00504 , B01J2208/00548 , B01J2219/00157 , B01J2219/002 , B01J2219/00213 , B01J2219/00231 , C01B3/323 , C01B3/38 , C01B3/48 , C01B3/583 , C01B2203/0233 , C01B2203/0283 , C01B2203/0288 , C01B2203/044 , C01B2203/0445 , C01B2203/047 , C01B2203/0495 , C01B2203/066 , C01B2203/0811 , C01B2203/0816 , C01B2203/0822 , C01B2203/0827 , C01B2203/0844 , C01B2203/0866 , C01B2203/0877 , C01B2203/0883 , C01B2203/1011 , C01B2203/1023 , C01B2203/1041 , C01B2203/1047 , C01B2203/1064 , C01B2203/107 , C01B2203/1076 , C01B2203/1082 , C01B2203/1223 , C01B2203/1241 , C01B2203/1247 , C01B2203/1288 , C01B2203/146 , C01B2203/1604 , C01B2203/1609 , C01B2203/1619 , C01B2203/1638 , C01B2203/1657 , C01B2203/1685 , C01B2203/169 , C01B2203/1695 , H01M8/04014 , H01M8/04022 , H01M8/04373 , H01M8/04738 , H01M8/04776 , H01M8/0612 , H01M8/0662 , Y02P20/128
摘要： The present invention relates to an electric power generator and its operation method, which electric power generator is equipped with a hydrogen generator, a polymer electrolyte fuel cell for generating electric power using hydrogen rich gas from the hydrogen generator, a burner for heating the hydrogen generator, a flow rate controller for controlling the supply amount of a burning fuel to the burner, a communicating pathway connecting the flow rate controller and the burner, a joint where at least a residual fuel gas from a fuel electrode of the fuel cell and/or an incompletely generated gas from the hydrogen generator are combined into the communicating pathway, and a pressure-transferring pipe for releasing the pressure between the joint and the flow rate controller into the flow rate controller; the flow rate controller controls the supply amount of the burning fuel on the basis of the above-mentioned pressure.
摘要翻译：发电机及其运行方法技术领域本发明涉及一种发电机及其运行方法，该发电机配备有氢发生器，使用来自氢发生器的富氢气体发电的聚合物电解质型燃料电池，用于加热氢发生器的燃烧器用于控制向燃烧器燃烧燃料的供给量的流量控制器，连接流量控制器和燃烧器的连通路径，至少来自燃料电池的燃料电极的残留燃料气体和/或来自氢发生器的不完全产生的气体被组合到连通通道中，以及用于将接头和流量控制器之间的压力释放到流量控制器中的压力传递管; 流量控制器基于上述压力控制燃烧燃料的供给量。

3. 发明授权

US5506205A Polypeptide of protein p140 and DNAs encoding it 失效
标题翻译：蛋白质p140的多肽和编码它的DNA
公开(公告)号：US5506205A
公开(公告)日：1996-04-09
申请号：US348143
申请日：1994-11-23
申请人： Hisao Tajima , Koichiro Kitagawa , Hiroyuki Ohno
发明人： Hisao Tajima , Koichiro Kitagawa , Hiroyuki Ohno
IPC分类号： A61K38/00 , C07K14/47 , C12N1/21 , C12N15/12 , C12P21/08 , C07K14/435 , C12N9/12
CPC分类号： C07K14/47 , A61K38/00
摘要： The present invention is related to a novel protein p140 polypeptide which is a key protein involved in the signal transmission system of insulin; method for preparation of it; DNA encoding the said polypeptide; vector comprising the DNA; host cells transformed with the vector; antibody against the polypeptide; pharmaceutical compositions containing the peptide or antibody; method for the prevention and/or treatment of diabetes, which is characterized by tyrosine phosphorylation of the said protein p140; agent for the prevention and/or treatment of diabetes, which is characterized by containing a compound which can tyrosine phosphorylate protein p140, as active ingredient and screening methods for the prevention and/or treatment agent.Tyrosine phosphorylation of protein p140 is an essential step in the induction of hypoglycemia by glucose uptake. Method and agent of prevention and/or treatment based on tyrosine phosphorylation of protein p140 in the present invention is not only to improves the diabetes-derived hyperglycemic conditions but are also useful for the treatment and/or prevention of diabetes, especially non-insulin dependent diabetes mellitus (NIDDM).
摘要翻译：本发明涉及胰岛素信号传递系统中涉及的关键蛋白质的新型蛋白质p140多肽，制备方法编码所述多肽的DNA; 包含DNA的载体; 宿主细胞用载体转化; 抗多肽抗体; 含有肽或抗体的药物组合物; 用于预防和/或治疗糖尿病的方法，其特征在于所述蛋白质p140的酪氨酸磷酸化; 用于预防和/或治疗糖尿病的药物，其特征在于含有可将酪氨酸磷酸化蛋白质p140的化合物作为活性成分和预防和/或治疗剂的筛选方法。蛋白质p140的酪氨酸磷酸化是通过葡萄糖摄取诱导低血糖的关键步骤。基于本发明的蛋白质p140的酪氨酸磷酸化的预防和/或治疗方法和药剂不仅可改善糖尿病来源的高血糖病症，而且可用于治疗和/或预防糖尿病，特别是非胰岛素依赖性糖尿病（NIDDM）。

4. 发明申请

US20120176892A1 Handover Parameter Control Apparatus and Method, and Computer Program 审中-公开
标题翻译：切换参数控制装置和方法以及计算机程序
公开(公告)号：US20120176892A1
公开(公告)日：2012-07-12
申请号：US13342455
申请日：2012-01-03
申请人： Toshiaki YAMAMOTO , Koichiro Kitagawa , Toshihiko Komine
发明人： Toshiaki YAMAMOTO , Koichiro Kitagawa , Toshihiko Komine
IPC分类号： H04W36/00 , H04L12/26
CPC分类号： H04W36/30
摘要： A handover parameter control apparatus in each cell of a cellular system having a condition in which if power received by a mobile terminal from a neighbor base station and power received from an access base station, to which the mobile terminal is connected, have power difference greater than or equal to a threshold, the mobile terminal executes handover from an access cell belonging to the access base station to a neighbor cell belonging to the neighbor base station. The apparatus includes a threshold control weight computation unit that computes a threshold control weight which indicates a threshold control direction so as to reduce handover failures, by using a frequency of first-type handover failure events which reduces by increasing the threshold; and a frequency of second-type handover failure events which reduces by decreasing the threshold; and a threshold determination unit that determines the threshold based on the threshold control weight.
摘要翻译：在蜂窝系统的每个小区中的切换参数控制装置具有如下条件：如果移动终端从邻近基站接收的功率和从接入基站接收到的功率与移动终端连接的功率具有较大的功率差移动终端执行从属于接入基站的接入小区到属于邻近基站的邻居小区的切换。该装置包括阈值控制权重计算单元，其通过使用通过增加阈值而减少的第一类型切换失败事件的频率来计算指示阈值控制方向以便减少切换失败的阈值控制权重; 以及通过降低阈值而减少的第二类切换失败事件的频率; 以及阈值确定单元，其基于所述阈值控制权重来确定所述阈值。

5. 发明授权

US06432913B1 Polypeptide of protein p140 and DNAs encoding it 失效
标题翻译：蛋白质p140的多肽和编码它的DNA
公开(公告)号：US06432913B1
公开(公告)日：2002-08-13
申请号：US09558340
申请日：2000-04-26
申请人： Hisao Tajima , Koichiro Kitagawa , Hiroyuki Ohno
发明人： Hisao Tajima , Koichiro Kitagawa , Hiroyuki Ohno
IPC分类号： A01N6100
CPC分类号： C07K14/47 , A61K38/00
摘要： The present invention is related to a novel protein p140 polypeptide which is a key protein involved in the signal transmission system of insulin; method for preparation of it; DNA encoding the said polypeptide; vector derived the said DNA; host cells transformed the said vector; antibody of the said polypeptide; pharmaceutical composition containing the said peptide or antibody; method for the prevention and/or treatment of diabetes, which is characterized by tyrosine phosphorylation of the said protein p140; agent for the prevention and/or treatment for the currently said the prevention and/or treatment method; agent for the prevention and/or treatment of diabetes, which is characterized by containing a compound which can tyrosine phosphorylation of protein p140, as active ingredient and the screening methods of the said prevention and/or treatment agent. Tyrosine phosphorylation of protein p140 is an essential step in the induction of hypoglycemia by glucose uptake. Method and agent of prevention and/or treatment based on tyrosine phosphorylation of protein p140 in the present invention is not only improve the diabetes-derived hyperglycemic conditions but are also useful for the treatment and/or prevention of diabetes, especially non-insulin dependent diabetes mellitus (NIDDM).
摘要翻译：本发明涉及胰岛素信号传递系统中涉及的关键蛋白质的新型蛋白质p140多肽，制备方法编码所述多肽的DNA; 载体衍生所述DNA; 宿主细胞转化所述载体; 所述多肽的抗体; 含有所述肽或抗体的药物组合物; 用于预防和/或治疗糖尿病的方法，其特征在于所述蛋白质p140的酪氨酸磷酸化; 用于预防和/或治疗目前所述的预防和/或治疗方法的药剂; 用于预防和/或治疗糖尿病的药物，其特征在于含有可以作为活性成分的蛋白质p140的酪氨酸磷酸化的化合物和所述预防和/或治疗剂的筛选方法。蛋白质p140的酪氨酸磷酸化是通过葡萄糖摄取诱导低血糖的关键步骤。本发明中基于蛋白质p140的酪氨酸磷酸化的预防和/或治疗方法和药剂不仅可以改善糖尿病来源的高血糖状况，而且可用于治疗和/或预防糖尿病，特别是非胰岛素依赖型糖尿病（NIDDM）。

6. 发明授权

US06303320B1 Polypeptide of protein P140 and DNAs encoding it 失效
标题翻译：蛋白P140的多肽和编码它的DNA
公开(公告)号：US06303320B1
公开(公告)日：2001-10-16
申请号：US09192435
申请日：1998-01-08
申请人： Hisao Tajima , Koichiro Kitagawa , Hiroyuki Ohno
发明人： Hisao Tajima , Koichiro Kitagawa , Hiroyuki Ohno
IPC分类号： G01N3353
CPC分类号： C07K14/47 , A61K38/00
摘要： The present invention is related to a novel protein p140 polypeptide which is a key protein involved in the signal transmission system of insulin; method for preparation of it; DNA encoding the polypeptide; vector derived with the DNA; host cells transformed with the vector; antibody of the polypeptide; pharmaceutical composition containing the peptide or antibody; method for the prevention and/or treatment of diabetes, which is characterized by tyrosine phosphorylation of the protein p140; agent for the prevention and/or treatment of diabetes, which is characterized by containing a compound which can tyrosine phosphorylate protein p140, as active ingredient and the screening methods of the prevention and/or treatment agent. Tyrosine phosphorylation of protein p140 is an essential step in the induction of hypoglycemia by glucose uptake. Method and agent of prevention and/or treatment based on tyrosine phosphorylation of protein p140 in the present invention not only improve the diabetes-derived hyperglycemic conditions but are also useful for the treatment and/or prevention of diabetes, especially non-insulin dependent diabetes mellitus (NIDDM).
摘要翻译：本发明涉及胰岛素信号传递系统中涉及的关键蛋白质的新型蛋白质p140多肽，制备方法编码多肽的DNA; 用DNA衍生的载体; 宿主细胞用载体转化; 多肽的抗体; 含有肽或抗体的药物组合物; 用于预防和/或治疗糖尿病的方法，其特征在于蛋白质p140的酪氨酸磷酸化; 用于预防和/或治疗糖尿病的药物，其特征在于含有可以酪氨酸磷酸化蛋白质p140的化合物作为活性成分和预防和/或治疗剂的筛选方法。蛋白质p140的酪氨酸磷酸化是通过葡萄糖摄取诱导低血糖的关键步骤。本发明中基于蛋白质p140的酪氨酸磷酸化的预防和/或治疗方法和药剂不仅改善糖尿病衍生的高血糖病症，而且可用于治疗和/或预防糖尿病，特别是非胰岛素依赖性糖尿病（NIDDM）。

7. 发明授权

US5804411A Polypeptide of protein P140 and DNAS encoding it 失效
标题翻译：蛋白质P140的多肽和编码它的DNAS
公开(公告)号：US5804411A
公开(公告)日：1998-09-08
申请号：US571785
申请日：1995-12-13
申请人： Hisao Tajima , Koichiro Kitagawa , Hiroyuki Ohno
发明人： Hisao Tajima , Koichiro Kitagawa , Hiroyuki Ohno
IPC分类号： A61K38/00 , C07K14/47 , C12N1/21 , C12N15/12 , C12P21/08 , C12P21/02 , C07H21/04 , C12N15/63
CPC分类号： C07K14/47 , A61K38/00
摘要： The present invention is related to a novel protein p140 polypeptide which is a key protein involved in the signal transmission system of insulin; method for preparation of it; DNA encoding the said polypeptide; vector derived the said DNA; host cells transformed the said vector; antibody of the said polypeptide; pharmaceutical composition containing the said peptide or antibody; method for the prevention and/or treatment of diabetes, which is characterized by tyrosine phosphorylation of the said protein p140; agent for the prevention and/or treatment of diabetes, agent for the prevention and/or treatment of diabetes, which is characterized by containing a compound which can tyrosine phosphorylate of protein p140, as active ingredient and the screening methods of the said prevention and/or treatment agent. Tyrosine phosphorylation of protein p140 is an essential step in the induction of hypoglycemia by glucose uptake. Method and agent of prevention and/or treatment based on tyrosine phosphorylation of protein p140 in the present invention is not only to improve the diabetes-derived hypoglycemic conditions but are also useful for the treatment and/or prevention of diabetes, especially non-insulin dependent diabetes mellitus (NIDDM).
摘要翻译：本发明涉及胰岛素信号传递系统中涉及的关键蛋白质的新型蛋白质p140多肽，制备方法编码所述多肽的DNA; 载体衍生所述DNA; 宿主细胞转化所述载体; 所述多肽的抗体; 含有所述肽或抗体的药物组合物; 用于预防和/或治疗糖尿病的方法，其特征在于所述蛋白质p140的酪氨酸磷酸化; 用于预防和/或治疗糖尿病的药剂，用于预防和/或治疗糖尿病的药剂，其特征在于含有可以将蛋白质p140的酪氨酸磷酸化的化合物作为活性成分，以及所述预防和/ 或治疗剂。蛋白质p140的酪氨酸磷酸化是通过葡萄糖摄取诱导低血糖的关键步骤。基于本发明的蛋白质p140的酪氨酸磷酸化的预防和/或治疗方法和药剂不仅可改善糖尿病衍生的低血糖状况，而且可用于治疗和/或预防糖尿病，特别是非胰岛素依赖性糖尿病（NIDDM）。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式